Some patients report that nighttime injection helps them sleep through nausea, but this is anecdotal and not formally studied in clinical trials
And on the horizon, with an FDA decision expected by April 10, 2026, is orforglipron, Eli Lilly's next-generation oral GLP-1 that could reshape the entire landscape of medically assisted weight management
Pao PC, Seo J, Lee A et al (2023) A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypes
At Nulevel Wellness Medspa, we assess each clients situation to determine the best course of action
Wellness and weight-loss injections are becoming increasingly common, especially with the rise of GLP-1 therapies and other compounded formulations that support energy, metabolism and overall wellness